What families need to know about a renewed debate over rules for nursing homes that sedate dementia patients.

Labour MSP Paul Sweeney has claimed there is a wider breakdown in patient safety at Stobhill Hospital in Glasgow, after an ...

A 20-year follow-up of older adults in the ACTIVE randomized trial linked to Medicare claims found that speed of processing cognitive training with booster sessions was associated with a significantly ...

Surviving cancer at a young age may come with an unexpected cost: faster aging at both the cellular and brain levels. Researchers found that survivors often show signs of being biologically older than ...

Summary: Women make up nearly two-thirds of Alzheimer’s patients, and researcher may have just discovered a massive reason why. A new study found that when the protein alpha-synuclein (typically ...

Houston Methodist scientists have uncovered an unexpected side of a protein best known for its link to brain diseases. The ...

The new generation of Alzheimer's disease drugs—the first proven to change the course of the disease—typically extend ...

Cognito raised $105 million as it awaits trial data that it hopes will convince the FDA to authorize its Alzheimer’s treatment device.

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.

More than 70 million baby boomers—those born between 1946 and 1964—are alive today. In 2026, the oldest of them are turning 80. With longer lives often comes more complicated health needs: multiple ...